Please login to the form below

Not currently logged in
Email:
Password:

ArQule

This page shows the latest ArQule news and features for those working in and with pharma, biotech and healthcare.

AZ drug matched to cancer mutation passes phase 2 test

AZ drug matched to cancer mutation passes phase 2 test

A rival AKT inhibitor from BioOncology – ipatasertib – also reported positive data at ASCO from the mid-stage LOTUS trial in first-line TNBC with similar gains seen, while ArQule also has

Latest news

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest appointments

  • X4 appoints John Celebi as COO X4 appoints John Celebi as COO

    Most recently, he served as chief business officer of Igenica Biotherapeutics, and has previously held senior positions at Agilent Technologies, ArQule, Biogen and Cyclis Pharmaceuticals.

  • Dr Jessie English joins Merck Dr Jessie English joins Merck

    During her two decades of work in oncology and immune-oncology research, she has also served as vice president of kinase biology at ArQule, oncology site lead for external discoveries at

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics